← FDA Drug Approvals (Drugs@FDA)
GRALISE
NDA · New Drug Application · Sponsor: ALMATICA · Approved 2011-01-28
Drug application
- FDA Application #
NDA022544- Application type
- New Drug Application
- Brand name
- GRALISE
- Generic name
- GABAPENTIN
- Active ingredients
- GABAPENTIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALMATICA
- Manufacturer
- Almatica Pharma LLC
- First approval
- 2011-01-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown